The Only Complete Online Marketing Firm
Wednesday, December 2, 2015
FDA Approves Second Antibody for Myeloma
(MedPage Today) -- Pivotal trial showed significant gain in PFS with elotuzumab
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment